In the univariate analysis for the total patient population at two years, the association of CCL18 with all-cause mortality was weaker (p = 0.087) but remained significant for cardiac death (p = 0.013), MI (p = 0.002) and stroke (p = 0.003). Here, CCL18 is linked to stroke disorder.